Scientists Recreated an Extinct Virus – Scientific American
Scientific American |
Scientists Recreated an Extinct Virus
Scientific American But some scientists fear that it could be revived through what’s known as synthetic biology — the ability to make a virus by putting together by the recipe outlined in its genetic code. The horsepox virus the Canadian team created is not a threat to … |
STAT |
What to watch for as Novartis heads to the FDA with a novel cancer therapy
STAT Novartis’ therapy, called CTL019, is a customized treatment made by harvesting patients’ white blood cells and rewiring them to home in on tumors. It’s the first so-called CAR–T therapy to come before the FDA, leading a pack of novel treatments that … Before Key Meeting, FDA Stresses Risks of Novartis CAR–T Cancer TherapyXconomy Safety issues for Novartis CAR–T therapy main focus of FDABioPharma Dive FDA panel to focus on safety of Novartis gene therapy drugReuters |
MIT News |
3 Questions: Angela Belcher and Kristala Prather on the promise of energy bioscience
MIT News Drawing upon MIT’s extensive existing research capability in synthetic biology, microbial metabolic engineering, new DNA technologies, and directed evolution, the center plans to rapidly screen, model, design, and synthesize new materials with … |
Multiple Sclerosis News Today |
Experts Call for Tighter Regulation of Stem Cell Therapies in Use at Clinics Worldwide
Multiple Sclerosis News Today Advertising for stem cell therapies not supported by clinical research — often made directly to patients and sometimes promoted as a “cure” for diseases like multiple sclerosis or Parkinson’s — is a growing problem that needs to be addressed and … |